Jinyu Bio-Technology Co., Ltd. (600201.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 11.79

From 52W high−33.81%

Volume8.89M

Market capCNY 13.67B

P/E (TTM)136.6x

P/S (TTM)9.3x

Div yield0.32%

Key dataSep 18, 2026

Open

CNY 11.79

From 52W high

−33.81%

Volume

8.89M

Market cap

CNY 13.67B

ValuationView details →

P/E (Fwd)

30.9x

EV/EBITDA

32.4x

P/E (TTM)

136.6x

RSI (14)

36.7

MomentumView details →

1D Return

−1.74%

YTD Return

−22.16%

ValuationView details →

P/E (Fwd)

30.9x

P/E (TTM)

136.6x

EV/EBITDA

32.4x

EV/Sales

8.5x

P/S (TTM)

9.3x

P/B (TTM)

2.5x

ProfitabilityView details →

Gross Margin

53.27%

Net Margin

7.49%

EBITDA Margin

26.13%

ROE (TTM)

1.91%

ROA (TTM)

1.60%

Asset Turnover

0.21x

GrowthView details →

Revenue YoY

+10.50%

EPS YoY

+30.41%

FCF YoY

−23.30%

Revenue CAGR 3Y

−2.97%

EPS CAGR 3Y

−22.05%

EBITDA YoY

—

MomentumView details →

1D Return

−1.74%

YTD Return

−22.16%

1Y Return

+30.33%

RSI (14)

36.7

vs 50D SMA

−5.42%

vs 200D SMA

−16.01%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

3.66x

Quick Ratio

3.26x

Div Yield

0.32%

Div Rate

CNY 0.04

Div Growth 1Y

+23.33%

EarningsView details →

EPS (Actual)

CNY 0.02

EPS Surprise

−90.07%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.08

Avg Surprise (4Q)

−90.07%

Rev Surprise

−19.98%

Financials snapshotView financials →

Revenue (TTM)

1.39B

Net Income (TTM)

104.27M

Op. CF (TTM)

301.31M

Next earningsNov 4, 2026 →

Latest newsMore news →

No recent news for 600201.SH.

Similar companies

Xcell Therapeutics, Inc.373110.KQ Summit Therapeutics Inc.SMMT 迈威生物-U688062.SH BridgeBio Pharma, Inc.BBIO Exelixis, Inc.EXEL Duality Biotherapeutics, Inc.09606.HK Find similar companies →

Latest newsMore news →

No recent news for 600201.SH.